| Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer G Viglietto, ML Motti, P Bruni, RM Melillo, A D'alessio, D Califano, F Vinci, ... Nature medicine 8 (10), 1136-1144, 2002 | 896 | 2002 |
| MicroRNA deregulation in human thyroid papillary carcinomas P Pallante, R Visone, M Ferracin, A Ferraro, MT Berlingieri, G Troncone, ... Endocrine-related cancer 13 (2), 497-508, 2006 | 646 | 2006 |
| An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue N Abe, T Watanabe, Y Suzuki, N Matsumoto, T Masaki, T Mori, ... British journal of cancer 89 (11), 2104-2109, 2003 | 396 | 2003 |
| RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. G Tallini, M Santoro, M Helie, F Carlomagno, G Salvatore, G Chiappetta, ... Clinical cancer research: an official journal of the American Association …, 1998 | 391 | 1998 |
| High level expression of the HMGI (Y) gene during embryonic development. G Chiappetta, V Avantaggiato, R Visconti, M Fedele, S Battista, ... Oncogene 13 (11), 2439-2446, 1996 | 384 | 1996 |
| RET/PTC oncogene activation is an early event in thyroid carcinogenesis. G Viglietto, G Chiappetta, FJ Martinez-Tello, FH Fukunaga, G Tallini, ... Oncogene 11 (6), 1207-1210, 1995 | 350 | 1995 |
| Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study A Bartolazzi, F Orlandi, E Saggiorato, M Volante, F Arecco, R Rossetto, ... The lancet oncology 9 (6), 543-549, 2008 | 343 | 2008 |
| High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid … GA Thomas, H Bunnell, HA Cook, ED Williams, A Nerovnya, ... The Journal of Clinical Endocrinology & Metabolism 84 (11), 4232-4238, 1999 | 327 | 1999 |
| Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. M Santoro, G Chiappetta, A Cerrato, D Salvatore, L Zhang, G Manzo, ... Oncogene 12 (8), 1821-1826, 1996 | 313 | 1996 |
| Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. G Viglietto, D Maglione, M Rambaldi, J Cerutti, A Romano, F Trapasso, ... Oncogene 11 (8), 1569-1579, 1995 | 298 | 1995 |
| RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of … KJ Rhoden, K Unger, G Salvatore, Y Yilmaz, V Vovk, G Chiappetta, ... The Journal of Clinical Endocrinology & Metabolism 91 (6), 2414-2423, 2006 | 253 | 2006 |
| The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells A Iannetti, F Pacifico, R Acquaviva, A Lavorgna, E Crescenzi, C Vascotto, ... Proceedings of the National Academy of Sciences 105 (37), 14058-14063, 2008 | 239 | 2008 |
| The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. G Chiappetta, A Bandiera, MT Berlingieri, R Visconti, G Manfioletti, ... Oncogene 10 (7), 1307-1314, 1995 | 226 | 1995 |
| Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung D Malanga, M Scrima, C De Marco, F Fabiani, N De Rosa, S De Gisi, ... Cell cycle 7 (5), 665-669, 2008 | 216 | 2008 |
| A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis A Vecchione, B Belletti, F Lovat, S Volinia, G Chiappetta, S Giglio, ... Proceedings of the National Academy of Sciences 110 (24), 9845-9850, 2013 | 208 | 2013 |
| PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1 P Bruni, A Boccia, G Baldassarre, F Trapasso, M Santoro, G Chiappetta, ... Oncogene 19 (28), 3146-3155, 2000 | 199 | 2000 |
| Detection of high mobility group I HMGI (Y) protein in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma G Chiappetta, G Tallini, MC De Biasio, G Manfioletti, FJ Martinez-Tello, ... Cancer research 58 (18), 4193-4198, 1998 | 193 | 1998 |
| Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias S Scala, G Portella, M Fedele, G Chiappetta, A Fusco Proceedings of the National Academy of Sciences 97 (8), 4256-4261, 2000 | 189 | 2000 |
| Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins M Fedele, A Bandiera, G Chiappetta, S Battista, G Viglietto, G Manfioletti, ... Cancer research 56 (8), 1896-1901, 1996 | 186 | 1996 |
| Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of … A Fusco, G Chiappetta, P Hui, G Garcia-Rostan, L Golden, BK Kinder, ... The American journal of pathology 160 (6), 2157-2167, 2002 | 180 | 2002 |
Alfredo FuscoProfessore di Patologia GeneraleVerified email at unina.it
